Zofran Plaintiffs Say GSK Hid FDA Lobbying From Discovery

By Dave Simpson · February 5, 2020, 11:03 PM EST

Citing what GlaxoSmithKline attorneys have called "some crazy conspiracy theory," plaintiffs claimed Wednesday that GSK hid from discovery its efforts to lobby the U.S. Food and Drug Administration about the multidistrict...

To view the full article, register now.

Documents

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

1:15-md-02657

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015